Genetic and Clinicopathologic Characteristics of Papillary Thyroid Carcinoma in the Chinese Population: High BRAF Mutation Allele Frequency, Multiple Driver Gene Mutations, and RET Fusion May Indicate More Advanced TN Stage-Reference-Cited by-同舟云学术

Genetic and Clinicopathologic Characteristics of Papillary Thyroid Carcinoma in the Chinese Population: High BRAF Mutation Allele Frequency, Multiple Driver Gene Mutations, and RET Fusion May Indicate More Advanced TN Stage

Published:2022-02 Issue: Volume:Volume 15 Page:147-157
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Wang Zhihong^ORCID,Tang Peng,Hua Surong,Gao Junyi,Zhang Bin,Wan Hua^ORCID,Wu Qixi,Zhang Jiaxin,Chen Ge

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference39 articles.

1. A rapidly increasing trend of thyroid cancer incidence in selected East Asian countries: Joinpoint regression and age-period-cohort analyses

2. Incidence and mortality of thyroid cancer in China, 2008−2012

3. Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients

4. Controversies in primary treatment of low-risk papillary thyroid cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-center Retrospective Cohort Study in a Chinese Population;Thyroid®;2024-08-30

2. Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features;Molecular Diagnosis & Therapy;2024-06-19

3. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study;Clinical and Experimental Medicine;2024-04-12

4. Selpercatinib: A narrative drug review;Cancer Research, Statistics, and Treatment;2024-01

5. The Impact of BRAF V600E Mutation Allele Frequency on the Histopathological Characteristics of Thyroid Cancer;Cancers;2023-12-25